The global biomarkers market, valued at US$58.07 billion in 2024 stood at US$62.39 billion in 2025 and is projected to ...

Medulloblastoma the most common malignant pediatric brain tumor with a high risk of metastasis and poor survival outcomes. To ...

In the first half of 2025, researchers around the world have published a wave of peer-reviewed studies examining the effects ...